AK3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.224200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.344800E-01
Normal-vs-Stage2
4.254000E-01
Normal-vs-Stage3
4.335800E-02
Normal-vs-Stage4
7.929000E-01
Stage1-vs-Stage2
6.219000E-01
Stage1-vs-Stage3
1.184560E-01
Stage1-vs-Stage4
8.326400E-01
Stage2-vs-Stage3
1.194850E-01
Stage2-vs-Stage4
5.099000E-01
Stage3-vs-Stage4
2.937800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.346800E-01
Normal-vs-AfricanAmerican
4.963600E-01
Normal-vs-Asian
2.307000E-01
Caucasian-vs-AfricanAmerican
8.917200E-01
Caucasian-vs-Asian
2.211800E-01
AfricanAmerican-vs-Asian
5.458200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.336800E-01
Normal-vs-Female
4.326200E-01
Male-vs-Female
9.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.865200E-01
Normal-vs-Age(41-60Yrs)
6.357600E-01
Normal-vs-Age(61-80Yrs)
3.587400E-01
Normal-vs-Age(81-100Yrs)
3.405600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.846800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.913800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.673200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.895600E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.128400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.478400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.185000E-01
Normal-vs-Daily Drinker
1.518830E-01
Normal-vs-Weekly Drinker
6.929400E-01
Normal-vs-Occasional Drinker
2.855400E-01
Normal-vs-Social Drinker
5.316000E-01
Non Drinker-vs-Daily Drinker
5.685800E-01
Non Drinker-vs-Weekly Drinker
2.884000E-01
Non Drinker-vs-Occasional Drinker
7.752000E-01
Non Drinker-vs-Social Drinker
4.269000E-01
Daily Drinker-vs-Weekly Drinker
1.735370E-01
Daily Drinker-vs-Occasional Drinker
4.389600E-01
Daily Drinker-vs-Social Drinker
2.434000E-01
Weekly Drinker-vs-Occasional Drinker
4.620400E-01
Weekly Drinker-vs-Social Drinker
7.958200E-01
Occasional Drinker-vs-Social Drinker
6.248600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.471400E-01
Normal-vs-Grade 2
9.361400E-01
Normal-vs-Grade 3
9.186000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.588600E-01
Grade 1-vs-Grade 3
6.673600E-01
Grade 1-vs-Grade 4
9.471400E-01
Grade 2-vs-Grade 3
7.289000E-01
Grade 2-vs-Grade 4
9.361400E-01
Grade 3-vs-Grade 4
9.186000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.025200E-01
Normal-vs-NonDiabetic
3.702600E-01
Diabetic-vs-NonDiabetic
3.580000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.970400E-02
Normal-vs-NoPancreatitis
3.532800E-01
Pancreatitis-vs-NoPancreatitis
8.677700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.343600E-01
Normal-vs-N1
3.905600E-01
N0-vs-N1
8.468800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.414600E-01
Normal-vs-TP53-NonMutant
6.215800E-01
TP53-Mutant-vs-TP53-NonMutant
2.041400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
